Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache
NCT07497646Completed
- Sponsor
- Sağlık Bilimleri Üniversitesi
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic migraine and tension-type headache (TTH) comparing Bupivacaine GON Blockade with Placebo GON Blockade (2 arms). Primary endpoint: Change from baseline in monthly number of headache days at Month 1. Started Jan 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
chronic migrainetension-type headache (TTH)
Beyond the preview
Go deeper on NCT07497646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497646.